Citation Impact
Citing Papers
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
2006
No health without mental health
2007 Standout
Systematic reviews of complementary therapies – an annotated bibliography. Part 3: Homeopathy
2001
Meta-analysis: Potentials and promise
1997
Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery
2001
Utilisation and Safety of Low Molecular Weight Heparins
2003
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
1994
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
1997
Low Molecular Weight Heparin
1997
Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials
2003
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
2007
Chlorpromazine versus placebo for schizophrenia
2007
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument
2003 Standout
Comparison of the Use of a Foot Pump with the Use of Low-Molecular-Weight Heparin for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement. A Prospective, Randomized Trial*
1998
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>
2002
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Large Trials vs Meta-analysis of Smaller Trials
1996
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison
2007
Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis
2016 Standout
Severe Sepsis and Septic Shock
2013 Standout
Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients
2003
Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2005
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
2001
Nadroparin in the Prevention of Deep Vein Thrombosis in Acute Decompensated COPD
2000
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
2010 Standout
Chronic kidney disease
2011 Standout
Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group
1997
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Publication and related bias in meta-analysis
2000 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Measuring inconsistency in meta-analyses
2003 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Diabetes and Atherosclerosis
2002 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Prevention of Venous Thromboembolism
2004 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial
2003
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
1996
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
What contributions do languages other than English make on the results of meta-analyses?
2000
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
2004
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
1995
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
Prevention of Venous Thromboembolism
2008 Standout
Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*
1997
Thromboembolic Prophylaxis with Use of Aspirin, Exercise, and Graded Elastic Stockings or Intermittent Compression Devices in Patients Managed with Total Hip Arthroplasty*
1999
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
An Epidemiologic Study of Risk Factors for Deep Vein Thrombosis in Medical Outpatients
2000
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Preoperative vs Postoperative Initiation of Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients Undergoing Elective Hip Replacement
1999
Cost-effective Prevention of Pulmonary Embolus in High-risk Trauma Patients
1997
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement
1997
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis
2004
An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Extended Venous Thromboembolism Prophylaxis After Total Hip Replacement<subtitle>A Comparison of Low-Molecular-Weight Heparin With Oral Anticoagulant</subtitle>
2002
Management of Anticoagulation before and after Elective Surgery
1997
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Adherence to Medication
2005 Standout
Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention
2015
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
Psychoeducation for schizophrenia
2011
Chlorpromazine versus placebo for schizophrenia
2014
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
Low Molecular Weight Heparin
1997
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
2001 Standout
Starting prophylaxis for venous thromboembolism postoperatively.
1995
Fatal pulmonary embolism in hospitalised medical patients.
1997
Haloperidol versus chlorpromazine for schizophrenia
2008
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
2000
Prophylaxis of postoperative thromboembolism with low molecular weight heparins
1993
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Low Molecular Weight Heparin versus Acenocoumarol in the Secondary Prophylaxis of Deep Vein Thrombosis
1999
Haloperidol dose for the acute phase of schizophrenia
2013
Perphenazine for schizophrenia
2015
Systematic reviews of trials and other studies.
1998
A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
1996
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin.
1999
Low-Molecular-Weight Heparins
1997 Standout
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
1997
Haloperidol versus placebo for schizophrenia
2013
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
1995
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery
1996
Prevention of Deep Vein Thrombosis after Hip Replacement
1999
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder
2002 Standout
Low‐Molecular‐Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial
1996
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery
2005
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Is There a “Best” Way to Detect and Minimize Publication Bias?
2001
Works of M. Haugh being referenced
Surrogate endpoints: A basis for a rational approach
1992
Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials
2002
Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction: Analysis of data from the EMIP study
1997
Introduction à la méthodologie métaanalytique
1995
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression
2000
Evidence of clinical efficacy of homeopathy
2000
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
2000
Critical reading of the meta-analysis of clinical trials.
1995
Ten-year audit of randomized trials in digestive surgery from Europe
2000